Voriconazole and Anidulafungin in Combination for Aspergillosis in Pediatric Subjects

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021231-14

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare safety and tolerability of voriconazole and anidulafungin in combination versus voriconazole alone in pediatric subjects aged 2 to 17 years with invasive aspergillosis.


Critère d'inclusion

  • Primary therapy of invasive aspergillosis (IA) in pediatric subjects aged 2 to 17 years